Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0001104659-22-037207
Filing Date
2022-03-24
Accepted
2022-03-24 06:03:11
Documents
18
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 40-F tm228756d1_40f.htm 40-F 55418
2 EXHIBIT 99.1 tm228756d1_ex99-1.htm EX-99.1 939299
3 EXHIBIT 99.2 tm228756d1_ex99-2.htm EX-99.2 472953
4 EXHIBIT 99.3 tm228756d1_ex99-3.htm EX-99.3 469774
5 EXHIBIT 99.4 tm228756d1_ex99-4.htm EX-99.4 7543
6 EXHIBIT 99.5 tm228756d1_ex99-5.htm EX-99.5 7132
7 EXHIBIT 99.6 tm228756d1_ex99-6.htm EX-99.6 3707
8 EXHIBIT 99.7 tm228756d1_ex99-7.htm EX-99.7 3533
9 EXHIBIT 99.8 tm228756d1_ex99-8.htm EX-99.8 5015
10 GRAPHIC image_006.jpg GRAPHIC 2140
11 GRAPHIC tm228756d1_40fimg001.jpg GRAPHIC 11374
12 GRAPHIC tm228756d1_ex99-1img001.jpg GRAPHIC 2863
13 GRAPHIC tm228756d1_ex99-1img002.jpg GRAPHIC 2063
14 GRAPHIC tm228756d1_ex99-1img004.jpg GRAPHIC 10133
15 GRAPHIC tm228756d1_ex99-2img001.jpg GRAPHIC 16451
16 GRAPHIC tm228756d1_ex99-2img002.jpg GRAPHIC 6465
17 GRAPHIC tm228756d1_ex99-3img001.jpg GRAPHIC 47360
18 GRAPHIC tm228756d1_ex99-8img001.jpg GRAPHIC 2807
  Complete submission text file 0001104659-22-037207.txt   2106887
Mailing Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5
Business Address 602-2265 UPPER MIDDLE ROAD EAST OAKVILLE A6 L6H 0G5 289-910-0850
Cardiol Therapeutics Inc. (Filer) CIK: 0001702123 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 40-F | Act: 34 | File No.: 001-40712 | Film No.: 22764608
SIC: 2836 Biological Products, (No Diagnostic Substances)